Stock Comparison
JAZZ vs REGN
Jazz Pharmaceuticals PLC and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$15.96B
$80.55B
P/E (TTM)
16.8
19.4
Forward P/E
10.3
17.1
Price/Sales
3.5
5.2
Price/Book
3.3
2.5
EV/EBITDA
11.3
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
0.66%
29.65%
Operating Margin
11.13%
24.32%
Return on Equity
22.10%
14.00%
Return on Assets
6.86%
6.53%
Growth (YoY)
Revenue Growth
15.50%
16.70%
Earnings Growth
3.20%
-4.50%
Price & Risk
Beta
0.4
0.2
52-Week High
$261.62
$810.12
52-Week Low
$116.67
$553.38
Analyst Target
$280.95
$833.54
Compare JAZZ and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.